SCHEMBL29978735

SCHEMBL29978735

O=C(O)c1cccnc1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.61
KDM4E B2RXH2 2/20 0.61
TRPV1 Q8NER1 12/20 0.53
ALDH1A1 P00352 2/20 0.49
CYP3A4 P08684 2/20 0.49
LMNA P02545 2/20 0.49
MEN1 O00255 1/20 0.49
GMNN O75496 1/20 0.49
TTR P02766 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
PKM P14618 1/20 0.49
NFKB1 P19838 1/20 0.49
UGT1A1 P22309 1/20 0.49
PTGS1 P23219 1/20 0.49
PTGS2 P35354 1/20 0.49
PMP22 Q01453 1/20 0.49
DHODH Q02127 1/20 0.49
KMT2A Q03164 1/20 0.49
TEAD4 Q15561 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4197626 1.00 TDP1 (0.61) TDP1KDM4ETRPV1ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL6201867 0.98 KDM4E (0.59) TDP1KDM4ETRPV1ALDH1A1CYP3A4
SCHEMBL5665026 0.86 TRPV1 (0.52) TRPV1
SCHEMBL6201866 0.86 TRPV1 (0.54) TRPV1
SCHEMBL3935826 0.84 KDM4E (0.61) TDP1KDM4ETRPV1ALDH1A1KMT2A
SCHEMBL473595 0.84 ALDH1A1 (0.59) TDP1KDM4ETRPV1ALDH1A1CYP3A4
SCHEMBL4206899 0.82 TRPV1 (0.54) TDP1TRPV1
SCHEMBL3712467 0.82 KDM4E (0.67) TDP1KDM4EALDH1A1CYP3A4LMNA
SCHEMBL6906432 0.82 KDM4E (0.71) TDP1KDM4EALDH1A1CYP3A4LMNA
SCHEMBL29453799 0.82 KDM4E (0.71) TDP1KDM4EALDH1A1CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists BAYER AKTIENGESELLSCHAFT (DE) 2025-08-26 US disclosed
EP-4058448-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer Aktiengesellschaft (DE) 2022-09-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists ADAMTS7, MMP7, ADAM17 TDP1 388/4885KDM4E 3062/4885TRPV1 2382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.